nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count  NCT04317040/Not yet recruiting,May‐May 2020–2022
Acute kidney injury in patients hospitalized with COVID‐19  –  China/COVID‐19 acute kidney injury‐kidney function  287, all, 18 years and older  Observational  Acute kidney injury:
COVID‐19 patients with acute kidney injury
nonacute kidney injury:
COVID‐19 patients without acute kidney injury  –
Rate of death, the length of hospital stay  Primary (up to 60 days):
Rate of acute kidney injury
Secondary (up to 60 days):  NCT04316299/Completed, Feb 26‐Mar8 2020
Phase I clinical trial in healthy adult  Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector)  COVID‐19  108, all, 18–60  Treatment